Filing Details

Accession Number:
0001213900-25-044863
Form Type:
13G Filing
Publication Date:
2025-05-15 20:00:00
Filed By:
Mark E. Strome
Company:
Cue Biopharma Inc. (NASDAQ:CUE)
Filing Date:
2025-05-16
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Mark E. Strome 0 2,166,242 4.99%
Strome Mezzanine Fund, LP 0 46,103 0.11%
Strome Mezzanine Fund II, LP 0 1,907,281 4.39%
Strome Dynasty, LLC. 0 162,629 0.38%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Mark E. Strome
 
Signature:/s/ Mark E. Strome
Name/Title:Mark E. Strome
Date:05/16/2025
 
Strome Mezzanine Fund, LP
 
Signature:/s/ Mark E. Strome
Name/Title:President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund, LP
Date:05/16/2025
 
Strome Mezzanine Fund II, LP
 
Signature:/s/ Mark E. Strome
Name/Title:President of Strome Group, Inc., the general partner of Strome Investment Management, LP, the general partner of Strome Mezzanine Fund II, LP
Date:05/16/2025
 
Strome Dynasty, LLC.
 
Signature:/s/ Mark E. Strome
Name/Title:Manager
Date:05/16/2025
Exhibit Information

99.1 Agreement of the Reporting Persons, dated May 16, 2025